Cargando…
Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963]
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155827/ https://www.ncbi.nlm.nih.gov/pubmed/37147236 http://dx.doi.org/10.1016/j.clim.2023.109246 |
_version_ | 1785036409835356160 |
---|---|
author | Wong, Matthew K. Liu, Jun T. Budylowksi, Patrick Yue, Feng Yun Li, Zhijie Rini, James M. Carlyle, James R. Zia, Amin Ostrowski, Mario Martin, Alberto |
author_facet | Wong, Matthew K. Liu, Jun T. Budylowksi, Patrick Yue, Feng Yun Li, Zhijie Rini, James M. Carlyle, James R. Zia, Amin Ostrowski, Mario Martin, Alberto |
author_sort | Wong, Matthew K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10155827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101558272023-05-04 Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] Wong, Matthew K. Liu, Jun T. Budylowksi, Patrick Yue, Feng Yun Li, Zhijie Rini, James M. Carlyle, James R. Zia, Amin Ostrowski, Mario Martin, Alberto Clin Immunol Corrigendum Published by Elsevier Inc. 2023-06 2023-05-03 /pmc/articles/PMC10155827/ /pubmed/37147236 http://dx.doi.org/10.1016/j.clim.2023.109246 Text en © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Corrigendum Wong, Matthew K. Liu, Jun T. Budylowksi, Patrick Yue, Feng Yun Li, Zhijie Rini, James M. Carlyle, James R. Zia, Amin Ostrowski, Mario Martin, Alberto Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] |
title | Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] |
title_full | Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] |
title_fullStr | Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] |
title_full_unstemmed | Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] |
title_short | Corrigendum to “Convergent CDR3 homology amongst Spike-specific antibody responses in convalescent COVID-19 subjects receiving the BNT162b2 vaccine” [Clinical Immunology 237 (2022) 108963] |
title_sort | corrigendum to “convergent cdr3 homology amongst spike-specific antibody responses in convalescent covid-19 subjects receiving the bnt162b2 vaccine” [clinical immunology 237 (2022) 108963] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155827/ https://www.ncbi.nlm.nih.gov/pubmed/37147236 http://dx.doi.org/10.1016/j.clim.2023.109246 |
work_keys_str_mv | AT wongmatthewk corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 AT liujunt corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 AT budylowksipatrick corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 AT yuefengyun corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 AT lizhijie corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 AT rinijamesm corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 AT carlylejamesr corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 AT ziaamin corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 AT ostrowskimario corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 AT martinalberto corrigendumtoconvergentcdr3homologyamongstspikespecificantibodyresponsesinconvalescentcovid19subjectsreceivingthebnt162b2vaccineclinicalimmunology2372022108963 |